-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
PharmaCielo Ships Dried Cannabis Flower To The Czech Republic, Expanding Its Exports To EU
PharmaCielo Ships Dried Cannabis Flower To The Czech Republic, Expanding Its Exports To EU
PharmaCielo Ltd. (OTCQX:PCLOF) (TSXV:PCLO) has made its first shipment of THC-dominant dried cannabis flower to a customer in the Czech Republic, in the EU market. The customer is an established cannabinoid-focused pharmaceutical distributor and clinical research organization in the country. The customer currently imports cannabinoids from The Netherlands and Canada.
Bill Petron, CEO of PharmaCielo, stated, "PharmaCielo's global business development team continues to make substantial progress growing the Company's sales pipeline and setting the stage for accelerated growth beginning in 2023. The EU is the biggest opportunity for global cannabinoid exporters, and PharmaCielo is positioned to win market share against current suppliers, with a combination of proprietary Colombian strains, high quality products and low production costs. Our team has made substantial progress in several markets recently, including Germany, Israel, Brazil, Mexico, Poland, and now the Czech Republic. We expect the combination of these recent developments and sustained sales efforts to make the next eighteen months a pivotal period for the company."
About PharmaCielo
PharmaCielo Ltd. is a global company, headquartered in Canada, with a focus on ethical and sustainable cultivating, processing and supply of all natural, pharmaceutical-grade medical dried cannabis flower and cannabis products to large channel distributors. PharmaCielo's principal subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its cultivation and processing center located in Rionegro, Colombia.
Photo by CRYSTALWEED cannabis on Unsplash
Related News
Update On Cannabis M&A: Aurora, TerrAscend, SNDL, Curaleaf, And... A Costly Preferred Stock Raise?
PharmaCielo Q2 Revenue Soars 375% YoY, Raises Additional $4.6M In Oversubscribed Debenture Financing
PharmaCielo Makes First Shipment Of Cannabinoid Products To Mexican Joint Venture Partner
PharmaCielo Ltd. (OTCQX:PCLOF) (TSXV:PCLO) has made its first shipment of THC-dominant dried cannabis flower to a customer in the Czech Republic, in the EU market. The customer is an established cannabinoid-focused pharmaceutical distributor and clinical research organization in the country. The customer currently imports cannabinoids from The Netherlands and Canada.
PharmaCielo Ltd.(多倫多證券交易所股票代碼:PCLOF)(多倫多證券交易所股票代碼:PCLO)首批以四氫大麻為主要成分的幹大麻花發送給位於捷克進軍歐盟市場。該客户是該國一家專注於大麻類藥物的老牌藥品分銷商和臨牀研究機構。該客户目前從荷蘭和加拿大進口大麻素。
Bill Petron, CEO of PharmaCielo, stated, "PharmaCielo's global business development team continues to make substantial progress growing the Company's sales pipeline and setting the stage for accelerated growth beginning in 2023. The EU is the biggest opportunity for global cannabinoid exporters, and PharmaCielo is positioned to win market share against current suppliers, with a combination of proprietary Colombian strains, high quality products and low production costs. Our team has made substantial progress in several markets recently, including Germany, Israel, Brazil, Mexico, Poland, and now the Czech Republic. We expect the combination of these recent developments and sustained sales efforts to make the next eighteen months a pivotal period for the company."
比爾·彼得龍PharmaCielo首席執行官表示:“PharmaCielo的全球業務開發團隊繼續在擴大公司的銷售渠道方面取得實質性進展,併為2023年開始的加速增長奠定了基礎。歐盟是全球大麻素出口商最大的機會,PharmaCielo憑藉哥倫比亞專有品種、高質量產品和低生產成本的組合,準備與現有供應商競爭贏得市場份額。我們的團隊最近在幾個市場取得了實質性進展,包括德國、以色列、巴西、墨西哥、波蘭,現在還有捷克共和國。我們預計,這些最新的發展和持續的銷售努力相結合,將使公司未來18個月成為關鍵時期。“
About PharmaCielo
關於PharmaCielo
PharmaCielo Ltd. is a global company, headquartered in Canada, with a focus on ethical and sustainable cultivating, processing and supply of all natural, pharmaceutical-grade medical dried cannabis flower and cannabis products to large channel distributors. PharmaCielo's principal subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its cultivation and processing center located in Rionegro, Colombia.
PharmaCielo有限公司是一家全球性公司,總部設在加拿大,專注於合乎道德和可持續的種植、加工和向大型渠道分銷商供應所有天然、藥用級醫用大麻乾產品。PharmaCielo的主要子公司是PharmaCielo哥倫比亞控股公司,總部設在哥倫比亞裏奧內格羅的種植和加工中心。
Photo by CRYSTALWEED cannabis on Unsplash
結晶器大麻在Unspash上的照片
Related News
相關新聞
Update On Cannabis M&A: Aurora, TerrAscend, SNDL, Curaleaf, And... A Costly Preferred Stock Raise?
大麻併購的最新消息:Aurora,TerrAscend,SNDL,Curaleaf和...代價高昂的優先股增資?
PharmaCielo Q2 Revenue Soars 375% YoY, Raises Additional $4.6M In Oversubscribed Debenture Financing
PharmaCielo第二季度營收同比飆升375%,額外籌集460萬美元超額認購債券融資
PharmaCielo Makes First Shipment Of Cannabinoid Products To Mexican Joint Venture Partner
PharmaCielo向墨西哥合資夥伴發運第一批大麻產品
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧